
Treatment for stomach cancer depends mostly on its stage and, for advanced disease, on biomarkers such as HER2. This Stomach Cancer Awareness Month explainer walks through the main options at each stage, based on National Cancer Institute guidance.
The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6 in Chicago! Clinicians and researchers gathered to present and discuss several updates in multiple myeloma relating to: Chimeric antigen receptor (CAR) T-cell therapies, Bispecific antibodies (also known as T-cell engagers) in combination or as monotherapy, Treatment for newly diagnosed disease, and Maintenance therapy. Let us break down the key findings for you…
Link:






